Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Sanofi India Limited
SANOFISanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. It also exports its products to approximately 35 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH. Address: Sanofi House, Mumbai, India, 400072
Analytics
Preço Alvo de Wall Street
785 823.24 INRRácio P/E
29.4894Rendimento de dividendos
2.47 %Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave SANOFI
Análise de Dividendos SANOFI
Crescimento de dividendos em 5 anos
430 %Crescimento contínuo
–Taxa de pagamento em média de 5 anos
132 %Histórico de Dividendos SANOFI
Avaliação de ações SANOFI
Relatório SANOFI
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |